RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
69 hedge funds and large institutions have $438M invested in Ra Pharmaceuticals, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
+7
Holders Change %
+11.29%
% of All Funds
1.58%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
13
Increased
29
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$37.1M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
$6.31M |
| 3 |
First Manhattan
New York
|
$19.4M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$7.87M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
$5.08M |
